Treatment for viral diseases

Details Treatment for viral diseases Treatment for viral diseases

1996-12-24

1998-05-12

Kumar, Shailendra

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514361, 514364, 514382, 514394, A61K 3141

Patent

active

057505519

ABSTRACT:
An angiotensin II antagonist compound is administered to mammals with viral disease. This administration ameliorates virus-associated cell injuries, producing therapeutic effects in viral diseases. This compound is also useful for the prevention of such diseases.

REFERENCES:
patent: 4216313 (1980-08-01), Paget et al.
patent: 4420479 (1983-12-01), Morwick et al.
patent: 4818761 (1989-04-01), Sato et al.
patent: 4956351 (1990-09-01), Mesens et al.
patent: 5294720 (1994-03-01), Jadhav et al.
patent: 5310740 (1994-05-01), Rosenberg et al.
patent: 5360795 (1994-11-01), Townsend et al.
patent: 5605919 (1997-02-01), Matsumori
J. Tanaka, "Effect of Angiotensin II Receptor Antagonist Drug (TCV-116) in Viral Myocarditis", Japanese Circulation Journal, vol. 57, Suppl. 1, p. 119, item 468, Mar. (1993).
Supplement to the Journal of the American College of Cardiology, vol. 21, No. 2, p. 197A (1993).
S. Rezkalla et al., Beneficial Effect of Captopril in Acute Coxsackievirs B.sub.3 Murine Myocarditis Circulation, vol. 81, No. 3, Mar. 1990.
A. Masumori, "Lessons from Animal Experiments in Myocarditis", Herz, vol. 17, No. 2, 1992, pp. 107-111.

Affiliated with

Also associated with

Rating

Treatment for viral diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for viral diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for viral diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-979356